|
1
|
Lipids changes in liver cancer.
|
J Zhejiang Univ Sci B
|
2007
|
1.06
|
|
2
|
Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.
|
World J Gastroenterol
|
2010
|
0.98
|
|
3
|
Review of Chinese clinical trials on CIK cell treatment for malignancies.
|
Clin Transl Oncol
|
2012
|
0.94
|
|
4
|
miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells.
|
Dig Dis Sci
|
2012
|
0.90
|
|
5
|
Clinical significance of CD44 variants expression in colorectal cancer.
|
Tumori
|
2013
|
0.88
|
|
6
|
Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China.
|
World J Surg Oncol
|
2013
|
0.88
|
|
7
|
Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer.
|
World J Gastroenterol
|
2004
|
0.84
|
|
8
|
Expression of costimulatory molecule B7-H4 in human malignant tumors.
|
Onkologie
|
2012
|
0.83
|
|
9
|
Clinical significance of serum ferritin in elderly patients with primary lung carcinoma.
|
Tumour Biol
|
2014
|
0.82
|
|
10
|
The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study.
|
Int J Hyperthermia
|
2010
|
0.82
|
|
11
|
Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
|
Onkologie
|
2013
|
0.82
|
|
12
|
Restoration of gefitinib efficacy following chemotherapy in a patient with metastatic non-small cell lung cancer.
|
Onkologie
|
2010
|
0.81
|
|
13
|
A novel mutation in CD40 and its functional characterization.
|
Hum Mutat
|
2009
|
0.81
|
|
14
|
Mechanisms and significance of lipoprotein(a) in hepatocellular carcinoma.
|
Hepatobiliary Pancreat Dis Int
|
2009
|
0.80
|
|
15
|
Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors.
|
J Transl Med
|
2014
|
0.80
|
|
16
|
Metabolism of high density lipoproteins in liver cancer.
|
World J Gastroenterol
|
2007
|
0.79
|
|
17
|
Serum VEGFR-3 and survival of advanced gastric cancer patients treated with FOLFOX.
|
World J Gastroenterol
|
2010
|
0.78
|
|
18
|
Serum ferritin is elevated in advanced non-small cell lung cancer patients and is associated with efficacy of platinum-based chemotherapy.
|
J Cancer Res Ther
|
2014
|
0.78
|
|
19
|
Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancer.
|
World J Gastroenterol
|
2011
|
0.78
|
|
20
|
Combined Therapy against Recurrent Hemangiopericytoma: A Case Report.
|
Cancer Biol Med
|
2012
|
0.78
|
|
21
|
CD40 mutant expression and its clinical significance to prognosis in gastric cancer patients.
|
World J Surg Oncol
|
2014
|
0.75
|
|
22
|
[Multicenter phase II study of modified FOLFIRI regimen in the advanced colorectal cancer patient refractory to fluoropyrimidine and oxaliplatin].
|
Zhonghua Zhong Liu Za Zhi
|
2006
|
0.75
|
|
23
|
Clinical application of serum alpha-fetoprotein-IgM complexes on the diagnosis of primary hepatocellular carcinoma in Kazakh and Han populations.
|
Tumori
|
2013
|
0.75
|
|
24
|
Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China.
|
Tumour Biol
|
2014
|
0.75
|